title: Conversion to tacrolimus in hyperlipidemic patients.
authors.affiliation: Medizinische Klinik II, Justus-Liebig-Universität Giessen, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Friemann
authors.forename: K
authors.initials: K
authors.lastname: Stopp
authors.forename: B
authors.initials: B
authors.lastname: Christ
authors.forename: R
authors.initials: R
authors.lastname: Weimer
authors.forename: W
authors.initials: W
authors.lastname: Padberg
authors.forename: W
authors.initials: W
authors.lastname: Ernst
mesh_terms: D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016559:Tacrolimus / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
chemical_list: D007166:Immunosuppressive Agents; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D016559:Tacrolimus